Lataa...
Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma
BACKGROUND: Osteosarcoma accounts for roughly 60% of all malignant bone tumors in children and young adults. The five-year survival rate for localized tumors after surgery and chemotherapy is approximately 70% whilst it drastically reduces to 15–30% in metastatic cases. Metabolic modulation is known...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101145/ https://ncbi.nlm.nih.gov/pubmed/30140384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25843 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|